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OBJECTIVES The goal of this study was to identify factors associated with radiofrequency catheter ablation
(RFCA) outcomes of intra-atrial re-entrant tachycardia (IART).
BACKGROUND Radiofrequency catheter ablation of IART is difficult. The influence of patient and procedural
factors and novel technologies on outcomes is unknown.
METHODS Acute and chronic RFCA outcomes were studied in patients with congenital heart disease
and IART. Clinical status was measured using a multiaxis severity score. Multivariate analyses
identified associations of clinical, procedural and technological factors with outcomes.
RESULTS A total of 177 procedures were performed in 134 patients; 139 procedures (79%) resulted in
RFCA of 1 IART circuit and 117 (66%) in RFCA of all targeted circuits. Multivariate
analysis associated acute success with irrigated ablation and absence of atrial fibrillation.
Twenty-two complications were noted, nine related to vascular access. Electroanatomic
mapping failed to decrease procedure or fluoroscopy time. Improvement in clinical status
occurred in most patients (severity score preablation: 6.2  1.6, postablation: 3.0  2.3, p 
0.0001). At mean follow-up of 25  11 months, 42% of patients had IART recurrence and
28% required cardioversion. Six deaths occurred (1.8%/patient-year), and two patients
underwent transplant. Chronic outcomes were associated with higher right atrial saturations,
use of electroanatomic mapping, fewer IART circuits encountered and acute procedural
success.
CONCLUSIONS Improvement of acute RFCA outcomes was contemporaneous with introduction of novel
technologies. Intra-atrial re-entrant tachycardia recurrence was common, and no effect on
mortality was discerned, but most patients had effective palliation of symptoms. Chronic
outcome predictors included the underlying disease severity, application of novel technologies
and successful ablation of all targeted arrhythmia circuits. (J Am Coll Cardiol 2002;39:
1827–35) © 2002 by the American College of Cardiology Foundation
Radiofrequency ablation procedures for treatment of intra-
atrial re-entrant tachycardia (IART) in patients with con-
genital heart disease (CHD) are technically demanding.
The earliest reports of clinical outcomes of IART ablation
predated the advent of nonfluoroscopic mapping techniques
and irrigated catheters (1–5). Techniques used to map
IART for ablative attempts in these series included fluoro-
scopic visualization of catheter position (5), inference of
surgical anatomy (2,4), entrainment pacing (3) and identi-
fication of “dead zones” of scarred tissue and split potentials
(1). Acute success was typically defined as the termination of
a targeted IART circuit by application of radiofrequency
energy, with subsequent ascertainment of “noninducibility”
by unspecified postablation atrial stimulation. Using this
approach, acute success rates were observed in the range of
70% to 100%, with a mean reported value of 78% drawn
from 132 patients in the five largest series (1–5). Although
some reports indicated spontaneous tachycardia recurrence
in only a minority of patients, one carefully documented
follow-up study of IART ablations revealed a recurrence
rate of 50% at 24-month follow-up of patients treated with
these conventional mapping and ablative techniques (6).
Recently, new clinical tools for spatially precise three-
dimensional activation mapping of IART have been re-
ported (7–9). These techniques have improved understand-
ing of the clinical mechanisms of IART circuits in patients
with CHD and the relations of these circuits to the
underlying atrial myocardial substrate. Additionally, novel
ablative techniques such as irrigation of the ablation catheter
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tip have been introduced, and their potential efficacy has
been demonstrated for the ablation of refractory accessory
pathways, common atrial flutter and ventricular tachycardia
(10–13). It remains unclear whether these newer mapping
and ablative techniques are associated with greater proce-
dural efficacy in IART.
The current study presents acute and intermediate term
data for a large, single-center series of patients with CHD
undergoing ablation of IART and explores the influence of
procedural and clinical variables, including the application
of novel mapping and ablative technologies, on clinical
outcomes.
METHODS
Retrospective analysis of the acute and intermediate term
outcomes of all patients with CHD undergoing attempted
ablation of IART at Boston Children’s Hospital between
January 1993 and December 2000 was performed. Clinical
records were reviewed with approval from the hospital’s
institutional review board. For those patients not followed
locally, referring cardiologists were contacted to assess
interim and current health and arrhythmia status. Outcomes
for patients who underwent radiofrequency catheter abla-
tion (RFCA) between January 1993 and December 1998
have been previously reported (5,6) and were updated for
this report.
Informed consent for clinical procedures was obtained in
accordance with hospital policies. All patients had a history
of sustained and/or recurrent atrial tachycardia. Patients
were studied under general anesthesia after hemodynamic
evaluation. Intra-atrial re-entrant tachycardia was defined as
a sustained (60 s) and entrainable atrial rhythm, induced
and/or terminated by pacing, independent of atrioventricu-
lar conduction, and with sudden onset and constant cycle
length (14).
Fluoroscopic mapping. Fluoroscopy was used as the pri-
mary guide for catheter placement in all cases performed
before January 1, 1999. Atrial angiography and spot fluo-
rography were used at the discretion of the operator to
record atrial anatomy and catheter location.
Electroanatomic mapping. Fluoroscopy was supplemented
by electroanatomic mapping in all patients catheterized after
January 1, 1999, using the CARTO system (Biosense
Webster, Inc., Diamond Bar, California). An interscapular
location reference sensor was applied and an atrial reference
electrode placed to record left atrial activation, either from
the coronary sinus or transesophageally. Activation mapping
was performed by initial systematic and broad sampling of
the atrial endocardial surface, followed by more detailed
mapping of areas of interest. In the event that patients
arrived in the catheterization laboratory in sustained IART,
mapping and ablation of the circuit were undertaken im-
mediately. More commonly, mapping of sinus and/or atri-
ally paced rhythm was undertaken to characterize the atrial
substrate, followed by induction of IART by atrial extra-
stimulation protocol (8), and burst atrial pacing when
necessary.
Standard RFCA. Standard ablation was performed using a
variety of power- and temperature-controlled catheters (7F,
4-mm electrode). Power was limited to 50 W and, in the
case of temperature-controlled catheters, tip temperature
was limited to 70°C. Power was delivered for up to 120 s per
lesion using either RFG-3C (Radionics, Burlington, Mas-
sachusetts) for power-controlled ablation or an Atakr
(Medtronic Cardiorhythm, San Jose, California) for
temperature-controlled ablation.
Irrigated ablation. Irrigated ablation was used in patients
who failed standard radiofrequency ablation and/or in
whom evidence of low-power output was observed at
ablation set point. Irrigated lesions were delivered by one of
two techniques. External sheath irrigation was performed
before the availability of internally irrigated catheter designs
by guiding 7F standard ablation catheters to the ablation
site using an 8F-long sheath advanced to the distal tip
electrode. Slow infusion of room temperature saline was
then manually delivered during radiofrequency application,
permitting higher power outputs without impedance rise.
Alternatively, an internally irrigated catheter with a closed
coolant system was used (Chilli, Cardiac Pathways, Inc.,
Sunnyvale, California). With this technique, lesions were
power-controlled, with manual titration of power input
until either an impedance drop of 10  to 15  or a tip
temperature 40°C was observed.
Acute outcome measures. Acute success was defined as
termination of an IART circuit during application of
radiofrequency energy without occurrence of an atrial extra-
systole or asynchronous pacing event, which was subse-
quently not induced by programmed stimulation. Limited
procedural success was defined as a procedure in which one
or more targeted IART circuits was acutely terminated
according to the definition noted in the previous text.
Complete procedural success was defined as a procedure in
which all targeted IART circuits were terminated according
to the definition noted in the previous text.
Clinical arrhythmia score. A multiscale index of clinically
relevant arrhythmia activity was used to compare severity of
IART immediately before ablation and at postablation
follow-up. Four subscores were summed to yield a clinical
arrhythmia score that ranged from 0 (no arrhythmia activ-
ity) to 12 points (severe, incessant and life-threatening
arrhythmia activity) (Table 1). This score was calculated
before ablation and at each subsequent follow-up visit for
which sufficient clinical information was available. Long-
term clinical outcome was determined from the subgroup of
procedures with: 1) preablation clinical arrhythmia score
Abbreviations and Acronyms
CHD  congenital heart disease
IART  intra-atrial re-entrant tachycardia
RFCA  radiofrequency catheter ablation
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5, and 2) clinical arrhythmia scores recorded 3 months
after the procedure. These limits were chosen to exclude
patients who had only mild symptoms before ablation or
who had insufficient follow-up to contribute to analysis of
chronic outcome. A long-term favorable outcome was
defined as mean and maximum follow-up scores that were
3 and that had decreased by 3 from the preprocedure
score. A long-term unfavorable outcome was defined as a
mean follow-up score that was 4 and that had decreased
by 2 from the preprocedure score.
Statistical analysis. Continuous data were summarized as
mean  SD or median (range) as appropriate. Univariate
comparisons were made using paired or unpaired t tests for
continuous data and Fisher exact test or chi-square for
categorical data. Multivariate data analysis was performed
using logistic regression, with binary end points of complete
procedural success and long-term outcome as defined above.
For the purposes of multivariate analysis, ambiguous long-
term outcomes that did not meet criteria for either outcome
group (e.g., insufficient follow-up, preablation arrhythmia
score 5) were not analyzed, resulting in a study group
smaller than that used for analysis of acute outcomes. For
multivariate logistic analyses, p-enter was chosen to be 0.08
and p-remove 0.10. Factor analysis was performed on the
same end points using principle component analysis and
varimax rotation with Kaiser normalization for definition of
factor groupings (SPSS for Windows, Version 10.0.5,
Chicago, Illinois).
RESULTS
Patient population. The study group consisted of 134
patients, with a mean age of 25.3  12.2 years (range 1
month to 62 years). The most common underlying anatom-
ical diagnoses were variants of single ventricle, tetralogy of
Fallot/ventricular septal defect and transposition of the
great vessels. All but two of the patients had prior cardiac
surgical intervention, with the Fontan procedure the most
common operation (Table 2).
A total of 177 ablative procedures were performed,
including 22 patients who had two procedures and 11
patients who had three procedures. Mean preablation clin-
ical arrhythmia score was 6.2  1.6 (n  165 procedures).
Irrigated lesions were applied in 39 procedures (first
irrigated procedure: #71, June 30, 1997), and electro-
anatomic mapping was utilized in 69 procedures (first
electroanatomic mapping procedure: #107, January 29,
1999). Patient characteristics were compared for patients
undergoing procedures with standard versus irrigated abla-
tion and standard versus electroanatomic mapping. These
showed that patients undergoing irrigated ablation had
hemodynamic signs of increased right atrial pressure (14
mm Hg vs. 11 mm Hg, p  0.003) and decreased cardiac
output (mixed venous saturation 66% vs. 70%, p  0.007
and atrioventricular O2 difference 31% vs. 27%, p  0.022),
consistent with a slight predominance of patients with the
Fontan procedure (72% vs. 45%, p  0.059) in this
population. The surgical and hemodynamic status and
Table 2. Anatomical Diagnoses and Surgical Status of
Study Group
Diagnostic Categories Patients
Single ventricle 46 Tricuspid atresia: 26 pts
Double inlet LV: 15 pts
Other: 5 pts
TOF/VSD 37
TGA and variants 29
ASD 7
Ebsteins 4
Other 11
Surgical Status Patients
Fontan 63 Older Fontan variants: 54 pts
Lateral tunnel: 9 pts
Biventricular repair 40
Mustard or Senning 22
Other 7
None 2
ASD atrial septal defect; LV left ventricle; pts patients; TGA transposition
of the great arteries; TOF  tetralogy of Fallot; VSD  ventricular septal defect.
Table 1. IART Clinical Severity Score
Documented IART Frequency of Cardioversion (Prior 3 Months)
None 0 points None 0 points
Nonsustained IART only 1 point One cardioversion 1 point
History of sustained IART 2 points AAIT cardioversions 1 point
Incessant IART 3 points Two or more cardioversions 3 points
IART Severity Antiarrhythmic Medications
No symptoms 0 points None or digoxin only 0 points
Palpitations only 1 point Class II or class IV 1 point
Syncope/CHF/thrombosis 2 points Class I or class III 2 points
Cardiac arrest 3 points Amiodarone toxicity 3 points
Score of 0 to 12 points is calculated as the sum of the highest score achieved in each of the four categories. Thrombosis
determined by either echocardiographic evidence of intracardiac thrombosis or clinical evidence of thromboembolic event. AAIT
cardioversions are defined as one or more automatic or manual cardioversions performed using an implanted atrial pacemaker and
not requiring any additional intervention. Amiodarone toxicity includes documented abnormalities of thyroid, hepatic or
pulmonary function attributed by clinician to amiodarone administration, whether or not necessitating discontinuation of
medication.
CHF  congestive heart failure, determined by review of clinical records and/or hemodynamic measurement; IART 
intra-atrial re-entrant tachycardia.
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clinical IART severity of patients undergoing electroana-
tomic mapping were similar to those undergoing standard
mapping.
Acute outcomes. A total of 369 distinct IART circuits
were encountered (median: 2 IART circuits/procedure,
range: 1 to 6), and 268 circuits were mapped (median:
1/procedure, range: 0 to 5). A total of 238 circuits were
targeted for ablation (median: 1/procedure, range: 0 to 5),
and 185 were terminated (median: 1/procedure, range: 0 to
5). Overall, one or more IART circuits were terminated
(limited procedural success) in 139/177 (79%) procedures,
and all targeted IART circuits were terminated (complete
procedural success) in 117/177 (66%) procedures.
Figure 1 shows acute success rate in sequential epochs of
ablation practice, categorized by technology applied (see
caption). These data show an increase in limited and
complete procedural success rates after the introduction of
irrigated ablation and electroanatomic mapping. Univariate
correlation of success rates by mapping and ablation tech-
nologies (without respect to procedure date) also showed
association between procedural success and technology.
Limited procedural success was increased in patients under-
going electroanatomic mapping (87% vs. 73%, p  0.029)
and irrigated ablation (92% vs. 75%, p  0.018), while
complete procedural success was increased in patients un-
dergoing irrigated ablation (85% vs. 61%, p  0.006).
Stepwise multivariate logistic regression showed that sig-
nificant, independent predictors of acute procedural success
were the use of irrigated ablation and the preablation
observation of atrial fibrillation (negative predictor)
(Table 3).
Univariate and multivariate analysis of clinical out-
comes. A total of 483 follow-up encounters were available
for analysis in 119 patients after 156 ablation procedures for
which an encounter was recorded at 3 months after
ablation (mean: 3.1 follow-up encounters/procedure). Total
follow-up duration for these procedures was 329 patient-
years, a mean of 25 months/procedure.
During the follow-up period, the clinical arrhythmia
score in all patients was reduced from a mean preablation
value of 6.2  1.6 to 3.0  2.3 (3.2 points, p  0.0001),
a finding that was stable over increasing duration of
Figure 1. Acute outcomes of intra-atrial re-entrant tachycardia ablation. In the initial 71 cases, standard techniques for mapping and ablation were used.
Irrigated ablation was applied in selected cases after that and was applied in 9/36 procedures using standard mapping techniques. Electroanatomic mapping
was used in 69/71 most recent procedures, with irrigated ablation used in 30 of those procedures. Black bars  complete procedural success (termination
of all targeted circuits); white bars  limited procedural success (termination of at least one circuit).
Table 3. Analyses of Acute Procedural Outcomes
(n  177 Procedures)
Univariate Analysis Multivariate Analysis
Complete
Success
Other
Acute Outcome p
Odds
Ratio CI p
Patient factors
Age at ablation (yrs) 25  12 26  11 0.633
RA mean pressure (torr) 12  5 11  6 0.447
Right atrial saturation (%) 68  7 70  10 0.391
Preablation arrhythmia score 6.2  1.7 6.0  1.6 0.467
Diagnosis of single ventricle () 51% 50% 0.875
Older-variant Fontan () 43% 47% 0.635
History of atrial fibrillation () 18% 32% 0.057 0.431 (0.201–0.925) 0.031
Learning curve/use of technology
Procedure date (mean) 3/3/98 4/28/97 0.013
Irrigated ablation () 28% 10% 0.007 3.801 (1.574–9.177) 0.003
Electroanatomical mapping () 44% 30% 0.103
CI  confidence interval; RA  right atrium.
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follow-up (Fig. 2A). A total of 43% of patients had an
electrocardiographically documented recurrence of IART
(sustained IART 60 s duration) after their most recent
ablative procedure, at a mean of 25  11 months, and 28%
have had a cardioversion, at a mean of 25  13 months.
Compared with patients with the Fontan procedure, pa-
tients with other anatomy had a somewhat lower overall rate
of documented IART recurrence (36% vs. 52%, p  0.077)
but a similar overall rate of cardioversion (25% vs. 32%, p 
0.451).
Of the 156 procedures with sufficient follow-up, 54 were
classified as long-term unfavorable outcomes and 52 as
long-term favorable outcomes (see definitions in Methods
section) for purposes of further analysis. There was no
difference in preablation clinical arrhythmia scores for the
two groups (favorable: 6.6  1.4 vs. unfavorable: 6.4  1.1,
p  0.432), with significant difference observed in
follow-up score, as contrived by the selection process (fa-
vorable: 0.9  1.0 vs. unfavorable: 5.2  1.5 at mean 20
months, p  0.0001). Distribution and follow-up trends in
clinical arrhythmia score are presented for these two groups
in Figure 2B. Descriptive univariate statistical comparisons
are presented for patient factors, procedural technologies
and acute procedural findings and outcomes in Table 4,
along with the results of stepwise multivariate logistic
regression analysis.
Univariate analysis revealed a number of predictors of
long-term favorable outcome. At a significance level of p 
Figure 2. Clinical arrhythmia score before radiofrequency (RF) ablation and during follow-up. (A) Aggregated scores for all procedures, mean values 
SD. (B) Individual follow-up scores and trend lines for procedures classified as long-term unfavorable outcome (open symbols, dashed line) and long-term
favorable outcome (closed symbols, solid line).
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0.1, the univariate predictors of favorable outcome were
higher right atrial saturation and complete procedural suc-
cess. Predictors of unfavorable outcome were diagnosis of
single ventricle, older variant of the Fontan procedure, a
prior history of atrial fibrillation and higher numbers of
IART circuits mapped and ablated. Multivariate logistic
regression identified higher right atrial saturation, complete
procedural success and use of electroanatomic mapping as
positive predictors of long-term favorable outcome, while
number of IART circuits was a negative predictor.
Factor analysis was performed to determine whether
variables could be combined linearly to account for outcome
variability. Using this approach, variables were clustered
into three groups, which together accounted for 58% of the
variability observed in the clinical outcome. The three
groupings could be characterized as: “use of new technol-
ogy” (dominant variables: procedure date, electroanatomic
mapping, irrigated ablation), “Fontan physiology” (domi-
nant variables: diagnosis of single ventricle, older variant of
Fontan) and “procedural complexity” (dominant variables:
number of IARTs encountered and number of IARTs
mapped).
Deaths, transplantation and procedural complications.
Six patients (4%) of the study group were deceased on
follow-up, with a median time of 11.5 months (range: 2
days to 66 months) to death after procedure. Two deaths
were sudden, occurring 11 and 12 months after the proce-
dure, both in patients without documented recurrence of
IART; in one of these, an atrial thrombus was diagnosed
echocardiographically. The single periprocedural death oc-
curred in a 45-year-old patient with palliated tricuspid
atresia and severe congestive heart failure in the setting of
incessant atrial tachycardias (IART and atrial fibrillation).
Death in this patient ensued from progressive, intractable
heart failure, ventricular and atrial tachycardias and hypo-
tension two days after apparently successful mapping and
ablation of two IART circuits. Two patients underwent
transplantation after IART ablation for hemodynamic in-
dications.
Procedural complications were encountered in 22 patients
(16%). Nine of these were femoral vascular access compli-
cations, which resolved. Injury to pacemaker lead function
was observed in three cases, and transient phrenic nerve
palsies, transient ischemic events or atrial/superior vena
caval thrombi were observed in two cases each. Also noted
in single patients were a renal embolic event, pleural
effusion, hemoptysis and complete heart block.
Pulsed fluoroscopy time (anteroposterior  lateral time:
65 min fluoroscopy vs. 87 min electroanatomic mapping,
p  0.001) and total procedure time (5 h 28 min fluoros-
copy vs. 6 h 2 min electroanatomic mapping, p  0.033)
were prolonged in all cases but longer in cases employing
electroanatomic mapping.
DISCUSSION
In this report, novel outcome measures and multivariate
statistical techniques were used to analyze a large series of
IART ablations in patients with CHD. In contrast to prior
smaller series on this topic, it was possible in this study to
correlate outcomes to factors specific to the patient and the
ablation procedure. While not a curative procedure in many
cases, the majority of patients showed substantial clinical
improvement in terms of practical end points such as need
for repeated cardioversion or use of antiarrhythmic drugs.
Multivariate analyses suggest that the utilization of ad-
vanced mapping and ablative technologies was, in part,
responsible for improved acute and chronic success. Clinical
Table 4. Analyses of Chronic Procedural Outcomes
(n  106 Selected Procedures)
Univariate Analysis Multivariate Analysis
Favorable Unfavorable p Odds Ratio CI p
Patient factors
Age at ablation (yrs) 23  11 26  11 0.193
RA mean pressure (torr) 11  4 12  5 0.703
Right atrial saturation (%) 71  8 68  7 0.043 1.075 (1.008–1.146) 0.028
Preablation arrhythmia score 6.5  1.4 6.3  1.1 0.358
Diagnosis of single ventricle () 39% 63% 0.019
Older-variant Fontan () 31% 54% 0.020
Atrial pacing () 49% 51% 0.849
History of atrial fibrillation () 8% 20% 0.093
Learning curve/use of technology
Procedure date (mean) 10/23/97 07/28/97 0.121
Irrigated ablation () 27% 17% 0.242
Electroanatomical mapping () 48% 33% 0.166 2.424 (0.940–6.252) 0.067
Procedural complexity and outcome
Number IART circuits mapped 1.6  0.8 2.0  1.1 0.025 0.577 (0.361–0.923) 0.022
Number IART circuits ablated 1.4  0.6 1.8  0.9 0.044
Number IART circuits terminated 1.3  0.7 1.2  1.0 0.778
Complete procedural success () 85% 54% 0.001 3.926 (1.299–11.868) 0.015
CI  confidence interval; IART  intra-atrial re-entrant tachycardia.
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outcomes also depend on a variety of patient-specific fac-
tors, including the presence of univentricular anatomy and
prior performance of the Fontan procedure, the complexity
of the arrhythmia substrate encountered and mapped during
the procedure and achievement of an acutely successful
ablation outcome. From our analysis, we conclude that the
acute outcomes of catheter ablation of IART are improving
and that ablation is a reasonable approach to management
of IART in the large group of patients who do not have a
specific hemodynamic defect as an indication for cardiac
surgery.
Factors contributing to acute outcome. A variety of
factors were significantly associated with acute success in
IART ablation, defined in this series as the ablation of all
targeted IART circuits. Multivariate analysis of these fac-
tors identified the use of catheter tip irrigation as a positive
association and a prior history of atrial fibrillation as a
negative association with procedural success.
The favorable effect of catheter irrigation may reflect the
difficulties creating transmural ablative lesions in low-flow
environments (15,16). An association of irrigation with
ablative success has been reported for postinfarction ven-
tricular tachycardia (13) and recurrent atrial flutter (17),
arrhythmia substrates that are likely to resemble that en-
countered in IART. The presence of low convective flow in
the atria has been predicted (18) and observed experimen-
tally (19) in certain types of surgical anatomy, particularly
older variants of the Fontan procedure. Temperature con-
trolled ablation in these conditions is likely to result in low
power applications and smaller ablative lesions. Addition-
ally, extensive lesions may be required to block anatomic
pathways of unfavorably large dimension, and atrial tissue
may be unusually thick and hypertrophied in postoperative
congenital heart patients, a finding that has been observed
anecdotally, but is not well documented in the literature.
Atrial fibrillation is likely to represent a marker for a
complex arrhythmia substrate and/or more severe hemody-
namic derangement. Both of these factors increase the
difficulty of the ablation procedure and the probability of
terminating the procedure without completing all targeted
ablations. This observation is of practical significance, as
nearly 15% of procedures in this series were performed on
patients with a history of atrial fibrillation. Kirsh et al. (20)
recently reported that, although IART is the most common
rhythm diagnosis at cardioversion of patients with congen-
ital heart disease, as many as 30% also have a history of atrial
fibrillation. Thus, patients with a documented history of
atrial fibrillation may comprise a subgroup that may be
better served by medical, surgical or device therapies.
Factors contributing to long-term outcome. In this re-
port, a long-term favorable outcome was considered to be a
significant and sustained reduction of a simple, multidimen-
sional score of arrhythmia symptoms and therapies. Multi-
variate analysis revealed that positive predictors of chronic
success included the successful ablation of all targeted
arrhythmias, the use of electroanatomic mapping to guide
ablation and higher right atrial saturation; mapping of a
larger number of IART circuits during catheterization was a
negative predictor of chronic success. Although anatomical
diagnosis of single ventricle and surgical anatomy consisting
of an older variant of the Fontan procedure showed univar-
iate association with poor chronic outcome, this was not a
factor in multivariate models, perhaps because of correlation
of this finding with right atrial saturation. These results
were echoed by factor analysis, which showed that most of
the variation in chronic outcome was accounted for by linear
combinations of highly correlated variables that roughly
described factors related to: 1) the availability of advanced
mapping and ablative technology, 2) the underlying cardiac
anatomy and severity of illness, and 3) the complexity of the
arrhythmias encountered during the procedure.
First recurrence of tachycardia has traditionally been used
as a gold standard for evaluation of efficacy of arrhythmia
therapy. Looking solely at first reported recurrence among
patients in the current series, patients with the Fontan
procedure were somewhat more likely to have documented
IART recurrences after attempts at catheter ablation of
IART. This stands in contrast with the multivariate analysis
of chronic success and reflects the fact that many patients in
this series, including those with Fontans, experienced a
substantial decrease in the frequency and severity of IART
symptoms and/or need for therapy after ablation despite one
or more documented IART recurrences.
Patients with biventricular anatomy of all varieties had
long-term freedom from recurrence in approximately 65%
of cases, a value that still compares unfavorably with
freedom from recurrence rates of 80% to 90% over similar
time frames in adult studies of atrial flutter ablation out-
comes (21,22). However, a more appropriate comparison
might be to the less favorable adult experience with atrial
flutter before adoption of bidirectional isthmus block as an
end point, as this well-validated procedural ablation end
point is difficult and often impossible to apply to congeni-
tally abnormal anatomy. The development of versatile,
validated techniques for the confirmation of conduction
block in diverse anatomical locations remains a challenge to
physicians engaged in the development of ablative tech-
niques for complex re-entrant arrhythmias.
Clinical arrhythmia score. We observed a discrepancy in
clinical outcomes measured by time to IART recurrence in
comparison with the overall improvement noted in the
clinical arrhythmia score. The following clinical vignette is
taken from this series: a patient requiring multiple cardio-
versions each week while on amiodarone before ablation
would be classified a “treatment failure” after ablation due to
a single documented episode of tachycardia occurring
months after ablation and off antiarrhythmic therapy. Given
the intermittence of arrhythmia recurrence, significant prac-
tical and theoretical problems exist in the determination and
use of time of first recurrence as an arrhythmia outcome
measure. This is especially true for patients with atrial
arrhythmia, in whom clinically relevant episodes of recur-
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rence may sometimes be difficult for the patient to detect,
due to variable atrioventricular conduction.
These problems have been recently analyzed by Kaem-
merer et al. (23), who demonstrated that atrial arrhythmia
recurrence in their study group was a complex stochastic
process and that a frequency-based outcome measure for
arrhythmia therapies may be markedly superior to time of
first recurrence for detection of treatment effect. In prospec-
tively designed studies, measurement of arrhythmia fre-
quency implies the need for dense and regular sampling of
cardiac rhythm over an extended time. For the current
study, we developed a scale for measurement of arrhythmia
activity that incorporated the dimensions of arrhythmia
frequency, severity of symptoms and need for medical and
interventional therapy. Similar scales have been used in the
past to assess quality of life outcomes in arrhythmia ablation
(22,24). In this way, we were able to obtain a global sense of
the impact of arrhythmia activity on the patient’s life, using
data that was easily available on a retrospective basis.
Although this scale has not been validated against other
measures of arrhythmia activity or quality of life indexes, it
provided an objective metric that was useful for defining
good and poor outcomes, facilitating analysis of patient and
procedural characteristics contributing to these outcomes.
Morbidity, mortality and procedural complications.
Overall mortality in our study group was 6 patients in 329
patient-years of follow-up or 1.8%/patient-year. Prior stud-
ies of patients with IART occurring after surgical palliation
of congenital heart defects suggest that annual mortality in
these patients may be similar or slightly higher (25,26). A
recent follow-up study of 94 Fontan patients by Ghai et al.
(27) indicated a mean survival of approximately 20 years, a
value that is consistent with our annualized mortality and
that was not strongly influenced by the occurrence of IART.
Among our mortalities and transplants, the majority was
attributable to hemodynamic deterioration, emphasizing the
overall severity of illness in this group. Unfortunately, this
observation also indicates that, although successful arrhyth-
mia control may favorably affect quality of life in these
patients, it may be difficult to measure an improvement in
overall mortality.
Approximately 10% of patients experienced a major
complication unrelated to vascular access but attributable to
the ablation procedure, including embolic phenomena and
systemic venous thrombus. As is the case with mortality, it
is unclear as to what extent these complications are a
manifestation of an atrial environment, which is now
understood to be thrombogenic, even in the absence of
intervention (27–30) and what role the creation of radio-
frequency ablation lesions in either the systemic or pulmo-
nary venous atrial chamber plays in triggering thrombosis.
Of interest, use of electroanatomic mapping resulted in a
paradoxical lengthening of fluoroscopy time in this difficult
group of patients. This suggests that, for the operators in
this study, electroanatomic mapping was not a sufficient
intuitive means of catheter navigation to obviate the need
for extensive use of biplane fluoroscopy.
Study limitations. Data for this study was acquired retro-
spectively, and number, interval and documentation of
follow-up encounters varied considerably between patients.
Although date of procedure was not strongly correlated with
acute or chronic outcomes, the fact that all procedures were
performed at a single center by a small number of operators
may have contributed to a learning curve effect, which has
been previously described in pediatric ablation (31). Al-
though this was not isolated in multivariate analysis, such an
effect may have contributed to the improvement in out-
comes associated with the advent of new mapping and
ablative technologies.
Conclusions. Acute outcomes of IART ablation in pa-
tients with congenital heart disease have improved contem-
poraneously with the introduction of novel technologies for
mapping and ablation of these arrhythmias. Although many
patients have had recurrence of IART, significant clinical
palliation of clinical symptoms has apparently been achieved
in our patient population. Predictors of chronic clinical
improvement include the underlying severity of the patient’s
heart disease, the application of advanced mapping ablative
technologies, the number of tachycardia circuits encoun-
tered and the successful acute ablation of all targeted
arrhythmia circuits.
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